| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1029672269 |
| P356 | DOI | 10.1186/GM228 |
| P932 | PMC publication ID | 3092099 |
| P698 | PubMed publication ID | 21392406 |
| P5875 | ResearchGate publication ID | 50362782 |
| P50 | author | Ara Darzi | Q336080 |
| Jeremy K. Nicholson | Q18720163 | ||
| James M. Kinross | Q39383681 | ||
| P2860 | cites work | Global systems biology and personalized healthcare solutions | Q79595182 |
| Selection of bacteria originating from a human intestinal microbiota in the gut of previously germ-free rats | Q79929580 | ||
| Characterization of the inhabitancy of mouse intestinal bacteria (MIB) in rodents and humans by real-time PCR with group-specific primers | Q80187758 | ||
| The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go away | Q80412522 | ||
| Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy | Q81088046 | ||
| Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy | Q81402823 | ||
| Development of the human infant intestinal microbiota | Q21003936 | ||
| Obesity alters gut microbial ecology | Q24531503 | ||
| Diversity of the human intestinal microbial flora | Q24544241 | ||
| A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
| Metagenomic analysis of the human distal gut microbiome | Q24633486 | ||
| A core gut microbiome in obese and lean twins | Q24649648 | ||
| Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes | Q24652180 | ||
| A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model | Q24654226 | ||
| A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome | Q27499182 | ||
| Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme | Q27665609 | ||
| An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
| Commensal host-bacterial relationships in the gut | Q28188763 | ||
| Bacteriotherapy using fecal flora: toying with human motions | Q28268775 | ||
| Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea | Q28269350 | ||
| Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics | Q28303404 | ||
| Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 | Q28509150 | ||
| Functional metagenomics: a high throughput screening method to decipher microbiota-driven NF-κB modulation in the human gut | Q28749067 | ||
| Bacterial community variation in human body habitats across space and time | Q29547432 | ||
| Ecological and evolutionary forces shaping microbial diversity in the human intestine | Q29547586 | ||
| Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 | ||
| An ecological and evolutionary perspective on human-microbe mutualism and disease | Q29614265 | ||
| An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system | Q29614267 | ||
| The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice | Q29614457 | ||
| Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 | Q29615053 | ||
| Succession of microbial consortia in the developing infant gut microbiome | Q29615811 | ||
| Human gut microbiota in obesity and after gastric bypass | Q29615813 | ||
| Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites | Q29619788 | ||
| 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data | Q29784220 | ||
| Quantitative Phylogenetic Assessment of Microbial Communities in Diverse Environments | Q30002324 | ||
| Maturation of the murine cecal microbiota as revealed by terminal restriction fragment length polymorphism and 16S rRNA gene clone libraries. | Q31065279 | ||
| Metagenomics: genomic analysis of microbial communities | Q31132850 | ||
| Medically important bacterial-fungal interactions | Q37720396 | ||
| Structure and function of the intestinal epithelial barrier in health and disease | Q38142953 | ||
| Species variation in the fecal metabolome gives insight into differential gastrointestinal function | Q39431405 | ||
| Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression | Q42942477 | ||
| The role of oral hygiene in inflammatory bowel disease | Q43602642 | ||
| Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics | Q44226354 | ||
| Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. | Q45947824 | ||
| Topographical variation in murine intestinal metabolic profiles in relation to microbiome speciation and functional ecological activity. | Q45984595 | ||
| The role of gut microbiota in drug response. | Q46012275 | ||
| Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents | Q46093540 | ||
| Drug metabolome of the simvastatin formed by human intestinal microbiota in vitro | Q46231097 | ||
| Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. | Q46414083 | ||
| Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. | Q46432616 | ||
| Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis | Q46786159 | ||
| Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models | Q48080119 | ||
| Experimental models for studying the microbial ecology in the intestinal tract. | Q51216913 | ||
| Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. | Q52595622 | ||
| Influence of diets containing high and low risk factors for colon cancer on early stages of carcinogenesis in human flora-associated (HFA) rats. | Q53441206 | ||
| "Flora Power"-- fecal bacteria cure chronic C. difficile diarrhea. | Q55034423 | ||
| Shotgun metaproteomics of the human distal gut microbiota | Q56978437 | ||
| The core gut microbiome, energy balance and obesity | Q57012032 | ||
| Global metabolic phenotyping in an experimental laparotomy model of surgical trauma | Q57218775 | ||
| The Gut Microbiota Predispose to the Pathophysiology of Acute Postradiotherapy Diarrhea | Q57241173 | ||
| Gut microbiota: a potential new territory for drug targeting | Q58045758 | ||
| Susceptibility of Human Metabolic Phenotypes to Dietary Modulation | Q58045940 | ||
| Rapid and Noninvasive Metabonomic Characterization of Inflammatory Bowel Disease | Q59880162 | ||
| Infectious history | Q73703818 | ||
| A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria | Q73919528 | ||
| Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis | Q33317609 | ||
| Long-term stability of the human gut microbiota in two different rat strains | Q33340477 | ||
| Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn's disease | Q33381601 | ||
| Microbiomic analysis of the bifidobacterial population in the human distal gut. | Q33419297 | ||
| Gnotobiotic rats harboring human intestinal microbiota as a model for studying cholesterol-to-coprostanol conversion | Q33497521 | ||
| Characterization of the oral fungal microbiome (mycobiome) in healthy individuals | Q33523794 | ||
| Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients | Q33593685 | ||
| Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. | Q33718086 | ||
| Therapy and epidemiology of autism--clostridial spores as key elements | Q34007199 | ||
| Viruses in the faecal microbiota of monozygotic twins and their mothers | Q34058882 | ||
| Metabonomics: a platform for studying drug toxicity and gene function | Q34139125 | ||
| Reshaping the gut microbiome with bacterial transplantation and antibiotic intake | Q34153634 | ||
| A molecular view of the intestinal ecosystem. | Q34440247 | ||
| Pharmaco-metabonomic phenotyping and personalized drug treatment | Q34515169 | ||
| The human microbiome: eliminating the biomedical/environmental dichotomy in microbial ecology | Q34602628 | ||
| Prebiotics, probiotics and helminths: the 'natural' solution? | Q34612250 | ||
| Human metabolic phenotype diversity and its association with diet and blood pressure. | Q34772005 | ||
| Human gut microbiome adopts an alternative state following small bowel transplantation | Q35006562 | ||
| Phylogenetic and gene-centric metagenomics of the canine intestinal microbiome reveals similarities with humans and mice | Q35018772 | ||
| Ecological control of the gastrointestinal tract. The role of probiotic flora | Q35348967 | ||
| Effects of intestinal microflora and the environment on the development of asthma and allergy | Q35685182 | ||
| Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics | Q35787456 | ||
| Gut microorganisms, mammalian metabolism and personalized health care | Q36094303 | ||
| Bioecologic control of the gastrointestinal tract: the role of flora and supplemented probiotics and synbiotics | Q36220414 | ||
| Metagenomics: DNA sequencing of environmental samples. | Q36320425 | ||
| Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model | Q36453694 | ||
| Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model | Q36837773 | ||
| Symbiotic gut microbes modulate human metabolic phenotypes | Q36883096 | ||
| TLR4 signalling in the intestine in health and disease | Q37010276 | ||
| The gastrointestinal microbiota as a site for the biotransformation of drugs | Q37235756 | ||
| Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism | Q37318311 | ||
| Therapeutic implications of manipulating and mining the microbiota | Q37511360 | ||
| Real-time PCR quantitation of clostridia in feces of autistic children | Q37597056 | ||
| The importance of the development of the intestinal microbiota in infancy | Q37601278 | ||
| P433 | issue | 3 | |
| P921 | main subject | microbiome | Q1330402 |
| P304 | page(s) | 14 | |
| P577 | publication date | 2011-03-04 | |
| P1433 | published in | Genome Medicine | Q15816848 |
| P1476 | title | Gut microbiome-host interactions in health and disease | |
| P478 | volume | 3 |
| Q33618653 | 'Someone should oversee it': patient perspectives on the ethical issues arising with the regulation of probiotics |
| Q37980065 | 1H NMR-based metabonomic applications to decipher gut microbial metabolic influence on mammalian health |
| Q60947155 | A Phylogeny-Regularized Sparse Regression Model for Predictive Modeling of Microbial Community Data |
| Q91782801 | A Review and Tutorial of Machine Learning Methods for Microbiome Host Trait Prediction |
| Q36163566 | A future perspective on neurodegenerative diseases: nasopharyngeal and gut microbiota |
| Q36193487 | A method for automated pathogenic content estimation with application to rheumatoid arthritis |
| Q35034558 | A method for selectively enriching microbial DNA from contaminating vertebrate host DNA. |
| Q37677325 | A phylogenomic view of ecological specialization in the Lachnospiraceae, a family of digestive tract-associated bacteria. |
| Q90390418 | A review on human fecal metabolomics: Methods, applications and the human fecal metabolome database |
| Q62111589 | A systematic review of gut-immune-brain mechanisms in Autism Spectrum Disorder |
| Q40785545 | Admission to the Intensive Care Unit is Associated With Changes in the Oral Mycobiome |
| Q28657873 | Air pollution effects on the gut microbiota: a link between exposure and inflammatory disease |
| Q90189684 | An Integrated Multi-Disciplinary Perspectivefor Addressing Challenges of the Human Gut Microbiome |
| Q89664723 | An association between air pollution and daily most frequently visits of eighteen outpatient diseases in an industrial city |
| Q44314783 | Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases |
| Q89688079 | Arsenic disturbs the gut microbiome of individuals in a disadvantaged community in Nepal |
| Q34741123 | Asthma microbiome studies and the potential for new therapeutic strategies |
| Q56525679 | Bacterial DNA patterns identified using paired-end Illumina sequencing of 16S rRNA genes from whole blood samples of septic patients in the emergency room and intensive care unit |
| Q39028856 | Bespoke microbiome therapy to manage plant diseases. |
| Q35777223 | Cancer: an emergent property of disturbed resource-rich environments? Ecology meets personalized medicine |
| Q38914856 | Captivity Shapes the Gut Microbiota of Andean Bears: Insights into Health Surveillance. |
| Q37524901 | Cell biology of ischemia/reperfusion injury |
| Q92391781 | Characteristics of Faecal Microbiota in Korean Patients with Clostridioides difficile-associated Diarrhea |
| Q27339851 | Characterization of the core rumen microbiome in cattle during transition from forage to concentrate as well as during and after an acidotic challenge |
| Q35126221 | Closing the gap between knowledge and clinical application: challenges for genomic translation |
| Q35589400 | Community assembly of a euryhaline fish microbiome during salinity acclimation |
| Q57471994 | Community profiling of the urinary microbiota: considerations for low-biomass samples |
| Q35850269 | Comparative Evaluation of DNA Extraction Methods from Feces of Multiple Host Species for Downstream Next-Generation Sequencing |
| Q57192057 | Comparative metagenomics of the gut microbiota in wild greylag geese (Anser anser) and ruddy shelducks (Tadorna ferruginea) |
| Q34407355 | Complementary symbiont contributions to plant decomposition in a fungus-farming termite. |
| Q28591805 | Comprehensive analysis of the fecal microbiota of healthy Japanese adults reveals a new bacterial lineage associated with a phenotype characterized by a high frequency of bowel movements and a lean body type |
| Q26825114 | Computational meta'omics for microbial community studies |
| Q64112342 | Conditional Regression Based on a Multivariate Zero-Inflated Logistic-Normal Model for Microbiome Relative Abundance Data |
| Q30885879 | Context-specific metabolic network reconstruction of a naphthalene-degrading bacterial community guided by metaproteomic data |
| Q42424691 | Controlling the Microbiome: Microhabitat Adjustments for Successful Biocontrol Strategies in Soil and Human Gut. |
| Q35470652 | Current and future trends in biomarker discovery and development of companion diagnostics for arthritis. |
| Q35737337 | Current nutritional recommendations and novel dietary strategies to manage sarcopenia |
| Q34039995 | Detecting epistatic interactions in metagenome-wide association studies by metaBOOST. |
| Q96683715 | Development of a plasma pseudotargeted metabolomics method based on ultra-high-performance liquid chromatography-mass spectrometry |
| Q96343186 | Developmental Origins of Health and Disease: Impact of environmental dust exposure in modulating microbiome and its association with non-communicable diseases |
| Q34629327 | Diagnostic metagenomics: potential applications to bacterial, viral and parasitic infections |
| Q96017572 | Dietary inflammatory potential in relation to the gut microbiome: results from a cross-sectional study |
| Q36649956 | Dietary patterns and colorectal cancer recurrence and survival: a cohort study |
| Q28817448 | Dietary strategies for improving iron status: balancing safety and efficacy |
| Q41861107 | Direct Detection and Quantification of Bacterial Genes Associated with Inflammation in DNA Isolated from Stool |
| Q35109207 | Diversity in gut bacterial community of school-age children in Asia |
| Q36251456 | Drosophila Genotype Influences Commensal Bacterial Levels |
| Q35630294 | Dysbiosis and Immune Dysregulation in Outer Space |
| Q91707059 | Effect of Mediterranean Diet Enriched in High Quality Extra Virgin Olive Oil on Oxidative Stress, Inflammation and Gut Microbiota in Obese and Normal Weight Adult Subjects |
| Q91644642 | Effects of niche overlap on coexistence, fixation and invasion in a population of two interacting species |
| Q35919704 | Efficacy of oral Bifidobacterium bifidum ATCC 29521 on microflora and antioxidant in mice. |
| Q30463597 | Efficient and robust RNA-seq process for cultured bacteria and complex community transcriptomes |
| Q37725583 | Elucidating the interactions between the human gut microbiota and its host through metabolic modeling |
| Q35058372 | Emerging roles of the microbiome in cancer |
| Q21135141 | Enteric microbiome metabolites correlate with response to simvastatin treatment |
| Q91902598 | Establishment and evaluation of prediction model for multiple disease classification based on gut microbial data |
| Q88776760 | Ethanolamine enhances intestinal functions by altering gut microbiome and mucosal anti-stress capacity in weaned rats |
| Q43744302 | Evaluation of postmortem bacterial migration using culturing and real-time quantitative PCR. |
| Q35591579 | Evidence for a link between gut microbiota and hypertension in the Dahl rat. |
| Q92420675 | Examination of the fecal microbiota in dairy cows infected with bovine leukemia virus |
| Q34696735 | Exercise attenuates PCB-induced changes in the mouse gut microbiome. |
| Q34241426 | Experimental and analytical tools for studying the human microbiome |
| Q90643029 | Exposure to atmospheric pollutants is associated with alterations of gut microbiota in spontaneously hypertensive rats |
| Q35552918 | Extensive strain-level copy-number variation across human gut microbiome species |
| Q57168725 | Factors Influencing Individual Variation in Farm Animal Cognition and How to Account for These Statistically |
| Q34995449 | Factors influencing the development of a personal tailored microbiota in the neonate, with particular emphasis on antibiotic therapy. |
| Q59129820 | Fecal bacterial microbiota of Canadian commercial mink (Neovison vison): Yearly, life stage, and seasonal comparisons |
| Q46860428 | Fecal volatile organic compounds: a novel, cheaper method of diagnosing inflammatory bowel disease? |
| Q35419213 | Fetal exposures and perinatal influences on the stool microbiota of premature infants |
| Q26827143 | From genomes to societies: a holistic view of determinants of human health |
| Q37690561 | Functional profiling of the gut microbiome in disease-associated inflammation |
| Q92534295 | Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome |
| Q36559073 | Genomic Analysis of the Human Gut Microbiome Suggests Novel Enzymes Involved in Quinone Biosynthesis |
| Q46762192 | Global metabolic profiling of animal and human tissues via UPLC-MS. |
| Q88127821 | Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders |
| Q28552586 | Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases |
| Q35847101 | Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition |
| Q26738283 | Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health |
| Q93223495 | Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline |
| Q37097933 | Gut indigenous microbiota and epigenetics |
| Q34924272 | Gut microbiome and anticancer immune response: really hot Sh*t! |
| Q46313746 | Gut microbiome composition is associated with cardiac disease in zoo-housed western lowland gorillas (Gorilla gorilla gorilla). |
| Q35125886 | Gut microbiome composition is associated with temperament during early childhood. |
| Q47100520 | Gut microbiome in multiple sclerosis: The players involved and the roles they play. |
| Q37719316 | Gut microbiome phenotypes driven by host genetics affect arsenic metabolism. |
| Q33728322 | Gut microbiota disturbance during antibiotic therapy: a multi-omic approach |
| Q27313830 | HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats |
| Q34533664 | Healthcare workers' hand microbiome may mediate carriage of hospital pathogens |
| Q28607663 | Host genetic variation impacts microbiome composition across human body sites |
| Q36295242 | Host-microbiota interactions in inflammatory bowel disease |
| Q96306955 | Human microbiome: an academic update on human body site specific surveillance and its possible role |
| Q47874427 | Human microbiota, blood group antigens, and disease |
| Q93081712 | Impact of Maternal Malnutrition on Gut Barrier Defense: Implications for Pregnancy Health and Fetal Development |
| Q92537887 | Impact of Sample Preservation and Manipulation on Insect Gut Microbiome Profiling. A Test Case With Fruit Flies (Diptera, Tephritidae) |
| Q37639805 | Impact of Westernized Diet on Gut Microbiota in Children on Leyte Island |
| Q38771879 | Impact of nutrition on pollutant toxicity: an update with new insights into epigenetic regulation |
| Q91917765 | Impact of oral probiotic Lactobacillus acidophilus vaccine strains on the immune response and gut microbiome of mice |
| Q56981031 | In vitro fermentation of potential prebiotic flours from natural sources: impact on the human colonic microbiota and metabolome |
| Q42185302 | Incidence of type 1 diabetes among Polish children ages 0-14 years from 1989-2012. |
| Q38068188 | Integration of datasets from different analytical techniques to assess the impact of nutrition on human metabolome |
| Q46652126 | Interaction between gut immunity and polysaccharides |
| Q26778722 | Interactions Between the Gastrointestinal Microbiome and Clostridium difficile |
| Q59329400 | Intestinal and Models to Study Host-Microbiome Interactions and Acute Stressors |
| Q21284481 | Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis |
| Q24628739 | Intestinal microbiota in human health and disease: the impact of probiotics |
| Q35151156 | Intrapartum antibiotics and childhood atopic dermatitis |
| Q38996605 | Investigating cholesterol metabolism and ageing using a systems biology approach |
| Q51741191 | Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome. |
| Q39109413 | Ischemia/Reperfusion |
| Q90626285 | Lactobacilli spp.: real-time evaluation of biofilm growth |
| Q46376244 | Leukotriene B4-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression |
| Q35907547 | Looking back at genomic medicine in 2011. |
| Q24594632 | Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement |
| Q92822562 | MICOM: Metagenome-Scale Modeling To Infer Metabolic Interactions in the Gut Microbiota |
| Q26771148 | Management of non-alcoholic fatty liver disease in 2015 |
| Q90282265 | Manipulation of the Gut Microbiome Alters Acetaminophen Biodisposition in Mice |
| Q47150473 | Measurements for a healthy gut |
| Q37053538 | Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes |
| Q92307079 | Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice |
| Q35101532 | MetaID: a novel method for identification and quantification of metagenomic samples |
| Q37106015 | Metabiotics: novel idea or natural development of probiotic conception |
| Q30279122 | Metabolic network modeling of microbial communities |
| Q30278086 | Metabolic network-guided binning of metagenomic sequence fragments. |
| Q26799820 | Metagenomic surveys of gut microbiota |
| Q37969585 | Metagenomics: key to human gut microbiota |
| Q33728333 | Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection |
| Q28481283 | Microbial co-occurrence relationships in the human microbiome |
| Q37291447 | Microbial symbionts: a resource for the management of insect-related problems |
| Q58769235 | Microbiota dysbiosis and its pathophysiological significance in bowel obstruction |
| Q36345318 | Microbiotal-Host Interactions and Hypertension. |
| Q64229138 | Minority species influences microbiota formation: the role of Bifidobacterium with extracellular glycosidases in bifidus flora formation in breastfed infant guts |
| Q38606166 | Moderate Exercise Has Limited but Distinguishable Effects on the Mouse Microbiome |
| Q57055438 | More than the sum of the parts: annual partitioning within spatial guilds underpins community regulation |
| Q44917386 | Multi-omics Comparative Analysis Reveals Multiple Layers of Host Signaling Pathway Regulation by the Gut Microbiota |
| Q40126531 | New perspectives regarding the antiviral effect of vitamin A on norovirus using modulation of gut microbiota |
| Q37409165 | Next generation sequencing and a new era of medicine |
| Q34641213 | Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota? |
| Q37556451 | Normal neonatal microbiome variation in relation to environmental factors, infection and allergy |
| Q38646836 | Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome. |
| Q36284049 | Novel molecular, structural and evolutionary characteristics of the phosphoketolases from bifidobacteria and Coriobacteriales. |
| Q61798694 | Offspring Microbiomes Differ Across Breeding Sites in a Panmictic Species |
| Q37594087 | Old dog, new trick: a direct role for leptin in regulating microbiota composition |
| Q38678269 | Opportunities and Challenges for Environmental Exposure Assessment in Population-Based Studies |
| Q35550821 | Oral administration of Bifidobacterim bifidum for modulating microflora, acid and bile resistance, and physiological indices in mice. |
| Q35120262 | Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi |
| Q38124254 | Pharmacometabonomics and personalized medicine |
| Q33860494 | Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics |
| Q30353254 | Polymorphism of HLA-B27: 105 subtypes currently known. |
| Q35065324 | Polysaccharides utilization in human gut bacterium Bacteroides thetaiotaomicron: comparative genomics reconstruction of metabolic and regulatory networks |
| Q55711827 | Predictive Modeling of Microbiome Data Using a Phylogeny-Regularized Generalized Linear Mixed Model. |
| Q50875926 | Pretreatment Combination Reduces Remote Organ Damage Secondary to Intestinal Reperfusion Injury in Mice: Follow-up Study. |
| Q35896143 | Probiotics and immunity: provisional role for personalized diets and disease prevention. |
| Q26852592 | Promise of personalized omics to precision medicine |
| Q39346164 | Protective influence of healthful nutrition on mechanisms of environmental pollutant toxicity and disease risks |
| Q28272991 | Quantifying your body: a how-to guide from a systems biology perspective |
| Q34043268 | Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients |
| Q40381350 | Recent advances and future perspective in microbiota and probiotics. |
| Q35483922 | Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes |
| Q40196908 | Rethinking paradigms for studying mechanisms of action of plant bioactives |
| Q43140468 | Running interference? Exercise and PCB-induced changes in the gut microbiome |
| Q35390024 | Sampling of intestinal microbiota and targeted amplification of bacterial 16S rRNA genes for microbial ecologic analysis |
| Q40965666 | Slow intestinal transit contributes to elevate urinary p-cresol level in Italian autistic children. |
| Q90044786 | Specific class of intrapartum antibiotics relates to maturation of the infant gut microbiota: a prospective cohort study |
| Q34936050 | Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults |
| Q38660498 | Stress and welfare in ornamental fishes: what can be learned from aquaculture? |
| Q37902902 | Studying the Enteric Microbiome in Inflammatory Bowel Diseases: Getting through the Growing Pains and Moving Forward |
| Q34651315 | Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity |
| Q58045562 | Surgical systems biology and personalized longitudinal phenotyping in critical care |
| Q43021133 | Symbiont-derived β-1,3-glucanases in a social insect: mutualism beyond nutrition |
| Q35328312 | Symbiosis, dysbiosis, and rebiosis-the value of metaproteomics in human microbiome monitoring |
| Q38767286 | Systematic Characterization and Analysis of the Taxonomic Drivers of Functional Shifts in the Human Microbiome |
| Q34637753 | Systematic genomic analysis reveals the complementary aerobic and anaerobic respiration capacities of the human gut microbiota |
| Q33824947 | Systems biology: personalized medicine for the future? |
| Q36564712 | Systems-level characterization of a host-microbe metabolic symbiosis in the mammalian gut |
| Q45954682 | Taxonomic and predicted metabolic profiles of the human gut microbiome in pre-Columbian mummies. |
| Q48047320 | The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis |
| Q90479348 | The Changes in the Frog Gut Microbiome and Its Putative Oxygen-Related Phenotypes Accompanying the Development of Gastrointestinal Complexity and Dietary Shift |
| Q37669836 | The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies |
| Q41826538 | The Plant as Metaorganism and Research on Next-Generation Systemic Pesticides - Prospects and Challenges |
| Q49223149 | The Resistance to Plague Infection among Meriones persicus from Endemic and Non-endemic Regions in Iran: The Role of Gut Microbiota. |
| Q38802303 | The human gut microbiome in health: establishment and resilience of microbiota over a lifetime |
| Q36770846 | The human microbiome as a reservoir of antimicrobial resistance. |
| Q34726528 | The human microbiome is a source of therapeutic drug targets |
| Q57037571 | The intake of grain fibers modulates cytokine levels in blood |
| Q33754027 | The interplay between host immune cells and gut microbiota in chronic inflammatory diseases |
| Q37918323 | The intestinal microbiota and chronic disorders of the gut. |
| Q102379432 | The microbiota of farmed mink (Neovison vison) follows a successional development and is affected by early life antibiotic exposure |
| Q58697026 | The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women |
| Q35567838 | The skin microbiome: Associations between altered microbial communities and disease |
| Q49573862 | The yin and yang of leukotriene B4 mediated inflammation in cancer. |
| Q38016806 | Therapeutic modulation of microbiota-host metabolic interactions. |
| Q90028283 | Thinking Outside the Cereal Box: Noncarbohydrate Routes for Dietary Manipulation of the Gut Microbiota |
| Q35871069 | Third-generation sequencing techniques and applications to drug discovery |
| Q28647500 | Tick microbiome: the force within |
| Q57810328 | Trimethylamine -Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function |
| Q37327715 | Triterpenoid herbal saponins enhance beneficial bacteria, decrease sulfate-reducing bacteria, modulate inflammatory intestinal microenvironment and exert cancer preventive effects in ApcMin/+ mice |
| Q33035147 | Understanding the Apothecaries Within: The Necessity of a Systematic Approach for Defining the Chemical Output of the Human Microbiome |
| Q34975280 | Understanding the interactions between bacteria in the human gut through metabolic modeling |
| Q34509256 | Unique secreted-surface protein complex of Lactobacillus rhamnosus, identified by phage display. |
| Q30406122 | Vaccinia and other viruses with available vaccines show marked homology with the HIV-1 envelope glycoprotein: the prospect of using existing vaccines to stem the AIDS pandemic. |
| Q35855890 | Variation in Rural African Gut Microbiota Is Strongly Correlated with Colonization by Entamoeba and Subsistence |
| Q90932695 | What can the gut microbiome teach us about the connections between child physical and mental health? A systematic review |
| Q52590675 | When the Nose Doesn't Know: Canine Olfactory Function Associated With Health, Management, and Potential Links to Microbiota. |
| Q34413421 | Yogurt: role in healthy and active aging. |
Search more.